Ondansetron Accord (Ondansetron)

Ondansetron Accord is a selective 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting in several clinical settings.

• Chemotherapy‑induced nausea and vomiting: helps reduce the frequency and severity of episodes.
• Radiation‑induced nausea and vomiting: provides prophylactic control.
• Post‑operative nausea and vomiting: decreases incidence after surgical procedures.
• Hyper‑emesis gravidarum: used off‑label in some regions to control severe pregnancy‑related vomiting.
• Anticipatory nausea: reduces nausea that occurs before chemotherapy sessions.

• Ondansetron blocks the serotonin 5‑HT3 receptors located in the central nervous system and gastrointestinal tract, preventing serotonin‑mediated activation of the vomiting centre in the brainstem. This inhibition reduces the neural signaling that triggers nausea and vomiting, providing symptomatic relief across multiple emetogenic triggers.

Ondansetron is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Constipation: occasional bowel movement changes.
• Diarrhoea: transient loose stools.
• Fatigue: feeling of tiredness.
• Dizziness: light‑headed sensation.
• Injection site pain: if administered intravenously.

Serious or Rare Side Effects

• Cardiac arrhythmia: QT interval prolongation.
• Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
• Serotonin syndrome: agitation, hyperreflexia, tremor when combined with serotonergic agents.
• Hepatic dysfunction: elevated liver enzymes.
• Severe constipation or intestinal obstruction.
• Vision changes: blurred vision or visual disturbances.

When prescribing Ondansetron Accord, clinicians should consider several safety aspects.

• Cardiac monitoring: assess baseline ECG in patients with known heart disease.
• Drug interactions: review concomitant medications that affect QT interval.
• Pregnancy: use only if clearly needed; weigh benefits against potential risks.
• Renal impairment: dose adjustment may be required in severe kidney dysfunction.
• Hepatic impairment: monitor liver function tests during therapy.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ondansetron can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Anti‑arrhythmic agents (e.g., amiodarone, quinidine): increase risk of QT prolongation.
• Certain antipsychotics (pharmacologic      ).
• Macrolide antibiotics      .

Moderate   g       . -       g   . -      . -   g  . -  . -  . -  . -  . -  . -  . -  g  . -  . -  . -  . -  . -  . -  . -  . -  . -  . -  g -  . -  . -  . -  . -  -  -  -  -  -  -  -  -  -  -  e -  g -  -  -  -  -  -  -  e -  -  -  -  e -  e -  e -  e -  -  e -